Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Type 2 diabetes mellitus (T2DM) has become the main cause of end stage renal disease (ESRD) in the past decade. Diabetic kidney disease (DKD) is one of the most serious complications of diabetes. In clinical practice, the diagnosis of DKD is based primarily on clinical criteria, that is, patients almost do not undergo renal biopsy, leading to many non-diabetic kidney diseases (NDKDs) being misdiagnosed as DKD, thus increasing the incidence rate of DKD. The incidence of NDKD is also higher in those with DM. To date, few cases of minimal change disease (MCD) among those with DKD have been reported. Here, we report a case of diabetic nephropathy with pathological diagnosis, which was considered to be complicated with MCD according to the medical history, and was completely relieved after glucocorticoid treatment.

Case Description: A 49-year-old male patient with a diabetes duration of 3 years was admitted to our hospital mainly because of "bilateral lower extremity edema for 1 month". The clinical manifestations were nephrotic syndrome and diabetic nephropathy, which were confirmed by renal biopsy. According to the medical history, DKD with MCD was considered. The patient received glucocorticoid for 6 months and was completely relieved of proteinuria.

Conclusion: Renal biopsy is helpful to differentiate diabetes with chronic kidney disease (CKD). DKD and DKD with MCD can be differentiated in the early stage of DKD but are difficult to differentiate in the late stage of DKD. In clinical practice, for such patients, we should also diagnose them carefully based on their medical history to reduce the misdiagnosis rate.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12313474PMC
http://dx.doi.org/10.3389/fendo.2025.1623272DOI Listing

Publication Analysis

Top Keywords

diabetic nephropathy
12
renal biopsy
12
medical history
12
dkd
10
minimal change
8
change disease
8
kidney disease
8
clinical practice
8
completely relieved
8
dkd mcd
8

Similar Publications

Aims: Diabetes is a global public health crisis, especially when it is accompanied by microvascular complications such as diabetic kidney disease (DKD). The purpose of this study was to explore the relationship between the combined lifestyle factors of diabetes patients and their joint effects with genetic risk and the risk of DKD.

Materials And Methods: We included individuals diagnosed with diabetes at baseline from UK Biobank.

View Article and Find Full Text PDF

Background: Diabetic nephropathy (DN) represents approximately 50 % of all chronic kidney disease cases. Given the established involvement of USP22 in DN progression, this study investigated its underlying regulatory mechanisms.

Methods: Mouse podocytes were treated with high glucose (HG), and a diabetic mouse model was established.

View Article and Find Full Text PDF

Histone methylation of kidney disease: fact or fantasy?

Ren Fail

December 2025

Department of Nephrology, The First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei, China.

Histone methylation (HMT), the enzymatic addition of methyl groups to specific histone residues by histone methyltransferases, constitutes a key regulatory mechanism in gene expression and post-translational modulation. Although studies have explored HMT's role in oncogenesis and other organ-specific disorders, HMT is now implicated in the pathogenesis of kidney diseases. A broad spectrum of experimental models, including both and systems, has demonstrated the involvement of HMT alterations in diverse renal pathologies such as acute kidney injury, renal fibrosis, diabetic nephropathy, lupus nephritis, polycystic kidney disease, kidney stones, renal cell carcinoma, and immunoglobulin A nephropathy.

View Article and Find Full Text PDF

Genome editing technologies, particularly clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9, have transformed biomedical research by enabling precise genetic modifications. Due to its efficiency, cost-effectiveness and versatility, CRISPR has been widely applied across various stages of research, from fundamental biological investigations in preclinical models to potential therapeutic interventions. In nephrology, CRISPR represents a groundbreaking tool for elucidating the molecular mechanisms underlying kidney diseases and developing innovative therapeutic approaches.

View Article and Find Full Text PDF

Organoids: their emerging essential role in pathological mechanisms and drug discovery of diabetes and its complications.

Front Pharmacol

August 2025

State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Beijing, China.

Diabetes mellitus is a metabolic disease with a high global prevalence, which affects blood vessels throughout the entire body. As the disease progresses, it often leads to complications, including diabetic retinopathy and nephropathy. Currently, in addition to traditional cellular and animal models, more and more organoid models have been used in the study of diabetes and have broad application prospects in the field of pharmacological research.

View Article and Find Full Text PDF